Reverse genetics systems

Patent metadata

Field	Value
Publication number	US-9821052-B2
Application number	US-201013388033-A
Country	US
Kind code	B2
Filing date	Jul 30, 2010
Priority date	Jul 31, 2009
Publication date	Nov 21, 2017
Grant date	Nov 21, 2017

Abstract

The invention provides various reverse genetics systems for producing segmented RNA viruses, wherein the systems do not require bacteria for propagation of all of their expression constructs.

First claim

The invention claimed is:

1. A non-bacterial DNA construct comprising a promoter and coding sequences for expressing at least two different genome segments of a segmented RNA virus, wherein the construct lacks both a bacterial origin of replication and a bacterial selection marker, wherein the at least two segments are selected from the group of segments consisting of PB2, PB1, PA, HA, NP, NA, M and NS, wherein the construct is linear, and, wherein the promoter is operatively linked for transcription in an eukaryotic host cell, wherein the eukaryotic host cell is a mammalian cell or avian cell.

2. A eukaryotic host cell comprising the non-bacterial construct of claim 1 .

3. A method for producing a segmented RNA virus, comprising a step of culturing a host cell of claim 2 such that expression of the RNA virus segments occurs to produce the virus.

4. The host cell of claim 2 , wherein the cell is a MDCK cell.

5. The non-bacterial DNA construct of claim 1 , wherein the coding sequences are for influenza virus A or B genome segments PB2, PB1, PA, NP, and NS.

6. A method for producing a segmented RNA virus, comprising
a) transfecting a host cell with the construct of claim 1 , and
b) culturing the host cell such that expression of the RNA virus segments occurs to produce the virus;
wherein the host cell is a mammalian or avian host cell.

7. A non-bacterial DNA construct comprising a promoter and coding sequences for expressing all eight genome segments of an influenza A or B virus, wherein the construct lacks both a bacterial origin of replication and a bacterial selection marker, wherein the promoter is operatively linked for transcription in an eukaryotic host cell, wherein the eukaryotic host cell is a mammalian cell or avian cell, and wherein the construct is linear.

8. A eukaryotic host cell comprising the non-bacterial construct of claim 7 .

9. A method for producing a segmented RNA virus, comprising a step of culturing a host cell of claim 8 such that expression of the RNA virus segments occurs to produce the virus.

10. The host cell of claim 8 , wherein the cell is a MDCK cell.

Assignees

• Dormitzer Philip
• Franti Michael
• Mason Peter
• Seqirus Uk Ltd

Inventors

• Dormitzer Philip
• Franti Michael
• Mason Peter

Classifications

• A61K39/12

  Viral antigens · CPC title

• A61K39/145 Primary

  Orthomyxoviridae, e.g. influenza virus · CPC title

• C12N2760/16122

  New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title

• C12N15/85

  for animal cells · CPC title

• C12N2760/16234

  Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein · CPC title